Found: 13
Select item for more details and to access through your institution.
Assessment of functional outcomes by Sheehan Disability Scale in patients with major depressive disorder treated with duloxetine versus selective serotonin reuptake inhibitors.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2016, v. 31, n. 1, p. 53, doi. 10.1002/hup.2500
- By:
- Publication type:
- Article
Ixekizumab and Ustekinumab Efficacy in Nail Psoriasis in Patients with Moderate-to-Severe Psoriasis: 52-Week Results from a Phase 3, Head-to-Head Study (IXORA-S).
- Published in:
- Dermatology & Therapy, 2020, v. 10, n. 4, p. 663, doi. 10.1007/s13555-020-00383-x
- By:
- Publication type:
- Article
Impact of Ixekizumab Treatment on Itch and Psoriasis Area and Severity Index in Patients with Moderate-to-Severe Plaque Psoriasis: An Integrated Analysis of Two Phase III Randomized Studies.
- Published in:
- Dermatology & Therapy, 2018, v. 8, n. 4, p. 621, doi. 10.1007/s13555-018-0267-9
- By:
- Publication type:
- Article
Clinical outcomes with olanzapine long-acting injection: impact of the 3-hour observation period on patient satisfaction and well-being.
- Published in:
- Neuropsychiatric Disease & Treatment, 2016, v. 12, p. 2737, doi. 10.2147/NDT.S107266
- By:
- Publication type:
- Article
A 6-year open-label study of the efficacy and safety of olanzapine long-acting injection in patients with schizophrenia: a post hoc analysis based on the European label recommendation.
- Published in:
- Neuropsychiatric Disease & Treatment, 2015, v. 11, p. 1349, doi. 10.2147/NDT.S79347
- By:
- Publication type:
- Article
Switching to olanzapine long-acting injection from either oral olanzapine or any other antipsychotic: comparative post hoc analyses.
- Published in:
- Neuropsychiatric Disease & Treatment, 2013, v. 9, p. 1737, doi. 10.2147/NDT.S50635
- By:
- Publication type:
- Article
An Analysis of Patient-reported Outcomes in IXORA-S: Comparing Ixekizumab and Ustekinumab over 52 Weeks in Moderate-to-severe Psoriasis.
- Published in:
- Acta Dermato-Venereologica, 2020, v. 100, n. 12, p. 1, doi. 10.2340/00015555-3700
- By:
- Publication type:
- Article
Absolute and Relative Psoriasis Area and Severity Indices (PASI) for Comparison of the Efficacy of Ixekizumab to Etanercept and Placebo in Patients with Moderate-to-severe Plaque Psoriasis: An Integrated Analysis of UNCOVER-2 and UNCOVER-3 Outcomes.
- Published in:
- Acta Dermato-Venereologica, 2019, v. 99, n. 11, p. 971, doi. 10.2340/00015555-3245
- By:
- Publication type:
- Article
A network meta-analysis of atomoxetine and osmotic release oral system methylphenidate in the treatment of attention-deficit/hyperactivity disorder in adult patients.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Depressed elderly on quetiapine XR show early and steady progress.
- Published in:
- Brown University Psychopharmacology Update, 2012, v. 23, n. 10, p. 1
- By:
- Publication type:
- Article
Relationships Between Functional Outcomes and Symptomatic Improvement in Atomoxetine-Treated Adult Patients with Attention-Deficit/Hyperactivity Disorder: Post Hoc Analysis of an Integrated Database.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Post Hoc Analysis of Potential Predictors of Response to Atomoxetine for the Treatment of Adults with Attention-Deficit/Hyperactivity Disorder using an Integrated Database.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Patterns of response to atomoxetine in the treatment of adult patients with Attention Deficit Hyperactivity Disorder.
- Published in:
- Klinik Psikofarmakoloji Bulteni, 2015, v. 25, p. S83
- By:
- Publication type:
- Article